Navigation Links
Isis Reports Reduction of apoB-100 Levels in a Murine Model Resulting in Up to 92% Reduction of Atherosclerosis
Date:4/18/2008

CARLSBAD, Calif., April 18 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) presented the results of two studies designed to assess the impact of lowering apoB-100 on atherosclerosis at the 2008 Annual Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Conference in Atlanta, Georgia. The data were presented in a poster entitled "Antisense Inhibition of Apolipoprotein B Ameliorated Diet-Induced Hypercholesterolemia and Reduced Atherosclerosis in LDL Receptor-Deficient Mice" by Adam E. Mullick, Ph.D. of Isis yesterday at ATVB.

Both studies were performed in a murine model in which the LDL receptor, which is responsible for the maintenance of normal serum cholesterol levels, has been genetically eliminated. These animals have very high cholesterol levels (1,000 - 2,000 mg/dL on a high fat diet) and develop severe atherosclerosis. In the first study, the impact of treatment with an antisense drug was evaluated in the context of two atherogenic high fat diets. Animals on these diets had elevated total cholesterol and LDL-cholesterol levels that increased during the two weeks of high fat diet prior to drug treatment. These cholesterol levels dramatically decreased during the 10 week treatment period. At a dose of 50 mg/kg twice weekly, the murine apoB-100 antisense drug reduced total cholesterol and LDL-cholesterol by 87% and 93%, respectively. These reductions in cholesterol directly correlated with reduction in liver and plasma apoB-100 levels. Aortic atherosclerotic lesions were reduced by 78% - 92% in the same animals.

The second study, which evaluated the effects of increasing doses of drug on lipid levels, confirms and extends the results of the previous study, and showed that the effects of the apoB-
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
2. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
6. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
7. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
8. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
9. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
10. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
11. New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 2014  Marta Rendon, MD, founder of the Rendon Center ... , FL and international key opinion leader in dermatology, was one ... United States to attend the international Aesthetic Experts ... . Here, at this gathering of over 600 physicians from ... plastic surgery experts from Asia and ...
(Date:11/24/2014)... , Nov. 24, 2014  Surgical Theater, LLC, announced ... November 24 th opening of Europe,s ... Neurologico Nazionale "C. Besta." The SuRgical Planner (SRP) and ... at the event for their 3D navigation and augmented ... Joshua Bederson , Professor and Chair, Department of Neurosurgery ...
(Date:11/24/2014)... England , Nov. 24, 2014  Pifflers ... https://www.facebook.com/PifflersUnited announced the release of results of ... therapy device, in the self-management of fibromyalgia pain. ... area of worst pain, very significant clinically meaningful ... The 140 group members with fibromyalgia used ActiPatch® ...
Breaking Medicine Technology:Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 3
... ASTRO Booth # 825 – At the American ... 2-6 in Miami Beach, Fla., Elekta will highlight its ... processes involved in radiation therapy, inspiring confidence in healthcare ... techniques are becoming increasingly sophisticated, requiring more time and ...
... Sept. 26, 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: ... a company that discovers and develops new uses for ... announced positive results from a 12-week open label extension ... Phase III trials for Zertane™ in patients with premature ...
Cached Medicine Technology:Elekta to Demonstrate How its Solutions Foster Confidence in Cancer Management at ASTRO Meeting in Miami 2Elekta to Demonstrate How its Solutions Foster Confidence in Cancer Management at ASTRO Meeting in Miami 3Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation. 2Ampio Announces Positive Results From 12-Week Open Label Extension Study of Zertane™ in Patients With Premature Ejaculation. 3
(Date:11/24/2014)... York (PRWEB) November 24, 2014 Gersowitz Libo ... that it has received national Tier recognition in the 2015 ... Achieving a tiered ranking signals a unique combination of quality ... very proud to receive this honor and especially grateful to ... this important honor and ranking possible,” said Jeff S. Korek, ...
(Date:11/24/2014)... Pittsburgh, PA (PRWEB) November 24, 2014 ... as he was trying to cross the street in ... "The driver never saw him. I came up with ... easily visible at night." , He developed the Safety ... night or in low-lighting conditions. The device ensures that ...
(Date:11/23/2014)... November 24, 2014 iFitDress.com, a well-known wedding ... black evening gowns . They are now offered at ... offer will last from now to Dec. 15. The main ... , All the company’s high quality items are ideal options ... a large sum of money. All its new mint cocktail ...
(Date:11/23/2014)... The report, “Market Snapshot: Aesthetic Lasers ... Asia-Pacific” provides quantitative analysis of the three aesthetic ... body contouring devices, non-invasive body contouring devices and ... data by revenue and volume over the 2006 ... South Korea, Australia and India. It uses data ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot water tank ... an 8 year warranty on its selected hot water tanks. ... due to the impending winter season, it was important for ... service that the company provides. As a result, Pro Ace ... and Bradford hot water tanks. , “Every installer who ...
Breaking Medicine News(10 mins):Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2
... School of Medicine have discovered that drinking just 500ml ... pressure. The study, published online today in the American ... the treatment of cardiovascular disease. , Lead by Professor ... Barts and The London School of Medicine, and Professor ...
... spending on medical research in Europe should be doubled ... welfare for Europes citizens and to nurture a thriving ... between European institutions in medical research and improved career ... the main recommendations of the European Medical Research Councils ...
... workforce raises serious,concerns, WASHINGTON, Feb. 5 ... strong objections to President,Bush,s FY2009 budget for both ... the FY 2009 budget reflects some poor choices ... setting a hazardous course for,the future., "The ...
... a clue leading researchers at Washington University School of ... approach for Niemann-Pick disease, a rare, deadly neurodegenerative disorder. ... disease, the researchers suggest that chemical compounds could potentially ... machinery. And they believe the approach also could be ...
... ... Xactly Incent on-demand solution, SAN JOSE, Calif., ... performance management, today announced that Volcano,Corporation (Nasdaq: VOLC ... diagnosis and treatment of vascular and structural heart,diseases, has ...
... ATLANTA, Feb. 5 Ingenious Med, leaders in ... practice management,announces record sales, product deployments, partnerships, and ... 2007 sales increased by,81% over 2006. This increase ... a,dramatic increase in IM,s overall profitability., In ...
Cached Medicine News:Health News:Research shows a daily does of beetroot juice can beat high blood pressure 2Health News:Collaboration needed for strengthening medical research in Europe 2Health News:Association of Academic Health Centers Faults Bush's FY 2009 Budget 2Health News:Chemical chaperone could open door to treatment of neurological disorder 2Health News:Chemical chaperone could open door to treatment of neurological disorder 3Health News:Volcano Corporation Selects Xactly to Drive Strategic Sales Performance Management 2Health News:Volcano Corporation Selects Xactly to Drive Strategic Sales Performance Management 3Health News:Ingenious Med Reports Record Sales and Client Expansions in 2007 2
... launched the first generation HPLC system for ... a new level of automation to HPLC ... diabetes testing in Japan. Now in the ... G7 offers advanced automation; stable HbA1c results ...
... complete hematology automation to maximize workflow efficiency ... provides the flexibility to meet your laboratory ... module, one Load module, and one Unload ... basic system will incorporate a minimum of ...
... The STart benchtop coagulation ... of electro-mechanical clot detection. This ... icteric or other optically dense ... offers programmable and preprogrammed assays ...
The CA-50 is a compact semi-automated coagulation analyzerproviding 4-parameter random access....
Medicine Products: